Regulation (EU) 2022/140
Commission Implementing Regulation (EU) 2022/140 of 16 November 2021 laying down rules for the application of Regulation (EU) 2016/429 of the European Parliament and of the Council with regard to the Union antigen, vaccine and diagnostic reagent banks (Text with EEA relevance)
In forceTyperegulationDate16 Nov 2021Since29 Apr 2024Articles9Versions held48Cited by7 documents
- 1Subject matter and scope
- 2Definitions
- 3Biological products to be included in the Union antigen, vaccine and diagnostic reagent banks for certain ca
- 4Additional requirements concerning the supply and storage of antigens and vaccines
- 5Requirements concerning the formulation of antigens of the foot and mouth disease virus into vaccines and th
- 6Procedures for the release and delivery of vaccines
- 7Requirements concerning the replacement of antigens, vaccines and diagnostic reagents
- 8Procedural and technical requirements for requesting access to the antigens, vaccines and diagnostic reagent
- 9Entry into force and application
- 1 ANNEX I Biological products to be included in the Union antigen, vaccine and diagnostic reagent banks as ref
- 2 ANNEX II Additional requirements concerning the storage of antigens and vaccines as referred to in Article 4
- 3 ANNEX III Requirements concerning the formulation of antigens of the foot and mouth disease virus into vacci
- 4 ANNEX IV Procedures for the release and delivery of vaccines formulated from the antigens of the foot and mo
- 5 ANNEX V Procedures for the delivery of vaccines stored in the Union vaccine banks as referred to in Article
- 6 ANNEX VI Additional criteria for the distribution of the required quantities and types of vaccines as referr
Source: EU legislation in force, consolidated versions and treaties (Cellar, Publications Office). Official publication. Reuse: Reuse authorised (Commission Decision 2011/833/EU).